• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的决策:神经科医生中对模糊性的厌恶在治疗惰性中的作用(DIScUTIR MS)

Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS).

作者信息

Saposnik Gustavo, Sempere Angel P, Prefasi Daniel, Selchen Daniel, Ruff Christian C, Maurino Jorge, Tobler Philippe N

机构信息

Division of Neurology, Stroke Outcomes and Decision Neuroscience Research Unit, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada; Laboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, Switzerland; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.

Department of Neurology, Hospital General Universitario de Alicante , Alicante , Spain.

出版信息

Front Neurol. 2017 Mar 1;8:65. doi: 10.3389/fneur.2017.00065. eCollection 2017.

DOI:10.3389/fneur.2017.00065
PMID:28298899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5331032/
Abstract

OBJECTIVES

Limited information is available on physician-related factors influencing therapeutic inertia (TI) in multiple sclerosis (MS). Our aim was to evaluate whether physicians' risk preferences are associated with TI in MS care, by applying concepts from behavioral economics.

DESIGN

In this cross-sectional study, participants answered questions regarding the management of 20 MS case scenarios, completed 3 surveys, and 4 experimental paradigms based on behavioral economics. Surveys and experiments included standardized measures of aversion ambiguity in financial and health domains, physicians' reactions to uncertainty in patient care, and questions related to risk preferences in different domains. The primary outcome was TI when physicians faced a need for escalating therapy based on clinical (new relapse) and magnetic resonance imaging activity while patients were on a disease-modifying agent.

RESULTS

Of 161 neurologists who were invited to participate in the project, 136 cooperated with the study (cooperation rate 84.5%) and 96 completed the survey (response rate: 60%). TI was present in 68.8% of participants. Similar results were observed for definitions of TI based on modified Rio or clinical progression. Aversion to ambiguity was associated with higher prevalence of TI (86.4% with high aversion to ambiguity vs. 63.5% with lower or no aversion to ambiguity;  = 0.042). In multivariate analyses, high aversion to ambiguity was the strongest predictor of TI (OR 7.39; 95%CI 1.40-38.9), followed by low tolerance to uncertainty (OR 3.47; 95%CI 1.18-10.2).

CONCLUSION

TI is a common phenomenon affecting nearly 7 out of 10 physicians caring for MS patients. Higher prevalence of TI was associated with physician's strong aversion to ambiguity and low tolerance of uncertainty.

摘要

目的

关于影响多发性硬化症(MS)治疗惰性(TI)的医生相关因素的信息有限。我们的目的是通过应用行为经济学的概念,评估医生的风险偏好是否与MS护理中的TI相关。

设计

在这项横断面研究中,参与者回答了有关20个MS病例场景管理的问题,完成了3项调查和4个基于行为经济学的实验范式。调查和实验包括金融和健康领域中对模糊性厌恶的标准化测量、医生对患者护理中不确定性的反应以及与不同领域风险偏好相关的问题。主要结果是当医生基于临床(新的复发)和磁共振成像活动需要升级治疗而患者正在使用疾病修饰药物时的TI。

结果

在被邀请参与该项目的161名神经科医生中,136名与研究合作(合作率84.5%),96名完成了调查(回复率:60%)。68.8%的参与者存在TI。基于改良的里约热内卢或临床进展对TI的定义也观察到了类似结果。对模糊性的厌恶与TI的较高患病率相关(对模糊性高度厌恶的为86.4%,对模糊性较低或无厌恶的为63.5%;P = 0.042)。在多变量分析中,对模糊性的高度厌恶是TI的最强预测因素(OR 7.39;95%CI 1.40 - 38.9),其次是对不确定性的低耐受性(OR 3.47;95%CI 1.18 - 10.2)。

结论

TI是一种常见现象,影响着近十分之七照顾MS患者的医生。TI的较高患病率与医生对模糊性的强烈厌恶和对不确定性的低耐受性相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48f/5331032/0ba618c8bd96/fneur-08-00065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48f/5331032/4f8bc2cf8bc1/fneur-08-00065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48f/5331032/0ba618c8bd96/fneur-08-00065-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48f/5331032/4f8bc2cf8bc1/fneur-08-00065-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48f/5331032/0ba618c8bd96/fneur-08-00065-g002.jpg

相似文献

1
Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS).多发性硬化症的决策:神经科医生中对模糊性的厌恶在治疗惰性中的作用(DIScUTIR MS)
Front Neurol. 2017 Mar 1;8:65. doi: 10.3389/fneur.2017.00065. eCollection 2017.
2
Emotional expressions associated with therapeutic inertia in multiple sclerosis care.多发性硬化症治疗惰性相关的情绪表达。
Mult Scler Relat Disord. 2019 Sep;34:17-28. doi: 10.1016/j.msard.2019.05.029. Epub 2019 Jun 4.
3
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).不确定性下的决策、治疗惰性与多发性硬化症管理中的医生风险偏好(DIScUTIR MS)
BMC Neurol. 2016 May 4;16:58. doi: 10.1186/s12883-016-0577-4.
4
Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain.比较加拿大、阿根廷、智利和西班牙的多发性硬化症患者管理中的医生治疗惰性。
JAMA Netw Open. 2019 Jul 3;2(7):e197093. doi: 10.1001/jamanetworkopen.2019.7093.
5
Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists.多发性硬化症治疗中的治疗惰性:一项针对加拿大神经科医生的研究。
Front Neurol. 2018 Sep 24;9:781. doi: 10.3389/fneur.2018.00781. eCollection 2018.
6
The Role of Prescribing Generic (Non-proprietary) Drugs in the Prevalence of Therapeutic Inertia in Multiple Sclerosis Care.开具通用名(非专利)药物在多发性硬化症治疗中治疗惰性流行率方面的作用。
Front Neurol. 2018 Oct 12;9:835. doi: 10.3389/fneur.2018.00835. eCollection 2018.
7
Effect of an Educational Intervention on Therapeutic Inertia in Neurologists With Expertise in Multiple Sclerosis: A Randomized Clinical Trial.教育干预对多发性硬化症专家神经科医生治疗惰性的影响:一项随机临床试验。
JAMA Netw Open. 2020 Dec 1;3(12):e2022227. doi: 10.1001/jamanetworkopen.2020.22227.
8
Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education.克服多发性硬化症护理中的治疗惰性:一项在医学教育中应用交通灯系统的试点随机试验
Front Neurol. 2017 Aug 21;8:430. doi: 10.3389/fneur.2017.00430. eCollection 2017.
9
Herding: a new phenomenon affecting medical decision-making in multiple sclerosis care? Lessons learned from DIScUTIR MS.从众行为:一种影响多发性硬化症护理中医疗决策的新现象?从DIScUTIR MS中吸取的教训
Patient Prefer Adherence. 2017 Jan 31;11:175-180. doi: 10.2147/PPA.S124192. eCollection 2017.
10
Therapeutic Decisions in Atrial Fibrillation for Stroke Prevention: The Role of Aversion to Ambiguity and Physicians' Risk Preferences.心房颤动中风预防的治疗决策:对模糊性的厌恶和医生风险偏好的作用。
J Stroke Cerebrovasc Dis. 2018 Aug;27(8):2088-2095. doi: 10.1016/j.jstrokecerebrovasdis.2018.03.005. Epub 2018 Apr 9.

引用本文的文献

1
Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey.多发性硬化症初始表现的管理方法:一项全球实践调查。
Neurol Clin Pract. 2025 Feb;15(1):e200376. doi: 10.1212/CPJ.0000000000200376. Epub 2024 Oct 9.
2
Unpacking workplace stress and forensic expert decision-making: From theory to practice.剖析职场压力与法医专家决策:从理论到实践
Forensic Sci Int Synerg. 2024 May 6;8:100473. doi: 10.1016/j.fsisyn.2024.100473. eCollection 2024.
3
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption.

本文引用的文献

1
Assessing response to interferon-β in a multicenter dataset of patients with MS.在一个多中心多发性硬化症患者数据集中评估对β-干扰素的反应。
Neurology. 2016 Jul 12;87(2):134-40. doi: 10.1212/WNL.0000000000002830. Epub 2016 Jun 15.
2
Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.西班牙神经病学学会2016年关于多发性硬化症治疗的共识声明。
Neurologia. 2017 Mar;32(2):113-119. doi: 10.1016/j.nrl.2016.02.026. Epub 2016 May 6.
3
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
早期在美国多发性硬化症中使用高效疗法:益处、障碍和鼓励采用的策略。
J Neurol. 2024 Jun;271(6):3116-3130. doi: 10.1007/s00415-024-12305-4. Epub 2024 Apr 14.
4
Therapeutic inertia in the management of neuromyelitis optica spectrum disorder.视神经脊髓炎谱系障碍治疗中的治疗惰性
Front Neurol. 2024 Feb 21;15:1341473. doi: 10.3389/fneur.2024.1341473. eCollection 2024.
5
Therapeutic inertia.治疗惰性
Aust Prescr. 2024 Feb;47(1):15-19. doi: 10.18773/austprescr.2024.001.
6
Clinician Risk Tolerance and Rates of Admission From the Emergency Department.临床医生风险承受能力与急诊科入院率。
JAMA Netw Open. 2024 Feb 5;7(2):e2356189. doi: 10.1001/jamanetworkopen.2023.56189.
7
Looking inside the lab: a systematic literature review of economic experiments in health service provision.审视实验室内部:卫生服务提供经济实验的系统文献综述。
Eur J Health Econ. 2024 Sep;25(7):1177-1204. doi: 10.1007/s10198-023-01662-y. Epub 2024 Jan 11.
8
Insights for Healthcare Providers on Shared Decision-Making in Multiple Sclerosis: A Narrative Review.医疗保健提供者对多发性硬化症共同决策的见解:一项叙述性综述。
Neurol Ther. 2024 Feb;13(1):21-37. doi: 10.1007/s40120-023-00573-7. Epub 2024 Jan 5.
9
Design of a Non-Interventional Study to Assess Neurologists' Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease.一项非干预性研究的设计,旨在评估神经科医生对早期阿尔茨海默病的看法和药物治疗决策。
Neurol Ther. 2023 Jun;12(3):995-1006. doi: 10.1007/s40120-023-00466-9. Epub 2023 Mar 23.
10
Unless Something Goes Wrong: Making Art to Understand and Mitigate the Risk of Therapeutic Inertia in the Treatment of Multiple Sclerosis.除非出现问题:通过艺术来理解和减轻多发性硬化症治疗中治疗惰性的风险
J Patient Exp. 2023 Jan 17;10:23743735231151550. doi: 10.1177/23743735231151550. eCollection 2023.
不确定性下的决策、治疗惰性与多发性硬化症管理中的医生风险偏好(DIScUTIR MS)
BMC Neurol. 2016 May 4;16:58. doi: 10.1186/s12883-016-0577-4.
4
Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.平衡多发性硬化症早期积极治疗与疾病进展风险
Can J Neurol Sci. 2016 Jan;43(1):33-43. doi: 10.1017/cjn.2015.302. Epub 2015 Nov 27.
5
Using Behavioral Economics to Design Physician Incentives That Deliver High-Value Care.利用行为经济学设计能够提供高价值医疗服务的医师激励机制。
Ann Intern Med. 2016 Jan 19;164(2):114-9. doi: 10.7326/M15-1330. Epub 2015 Nov 24.
6
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.用于复发缓解型多发性硬化症的免疫调节剂和免疫抑制剂:一项网状荟萃分析。
Cochrane Database Syst Rev. 2015 Sep 18;2015(9):CD011381. doi: 10.1002/14651858.CD011381.pub2.
7
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.循证指南:磁共振成像在多发性硬化中的应用——建立疾病预后和监测患者的 MAGNIMS 共识指南。
Nat Rev Neurol. 2015 Oct;11(10):597-606. doi: 10.1038/nrneurol.2015.157. Epub 2015 Sep 15.
8
Cognitive biases and heuristics in medical decision making: a critical review using a systematic search strategy.医学决策中的认知偏差与启发式方法:运用系统检索策略的批判性综述
Med Decis Making. 2015 May;35(4):539-57. doi: 10.1177/0272989X14547740. Epub 2014 Aug 21.
9
Cognitive overload? An exploration of the potential impact of cognitive functioning in discrete choice experiments with older people in health care.认知过载?一项关于认知功能对老年人群在医疗保健中的离散选择实验潜在影响的探索。
Value Health. 2014 Jul;17(5):655-9. doi: 10.1016/j.jval.2014.05.005. Epub 2014 Jun 25.
10
A model measuring therapeutic inertia and the associated factors among diabetes patients: A nationwide population-based study in Taiwan.一项衡量糖尿病患者治疗惰性及相关因素的模型:台湾一项基于全国人口的研究。
J Clin Pharmacol. 2015 Jan;55(1):17-24. doi: 10.1002/jcph.367. Epub 2014 Jul 28.